Health Canada - Federal department responsible for drug approvals and health regulation in Canada
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| DESVENLAFAXINE | SANIS HEALTH INC | Marketed | May 25, 2023 | Marketed |
| DESVENLAFAXINE | sanis health inc | Marketed | May 25, 2023 | Marketed |
| SANDOZ SUNITINIB | Sandoz Canada, Inc. | Marketed | May 24, 2023 | Marketed |
| JAMP POSACONAZOLE | Jamp Pharma Corporation | Marketed | May 24, 2023 | Marketed |
| CORZYNA | kye pharmaceuticals inc. | Marketed | May 24, 2023 | Marketed |
| SANDOZ SUNITINIB | Sandoz Canada, Inc. | Marketed | May 24, 2023 | Marketed |
| SANDOZ SUNITINIB | Sandoz Canada, Inc. | Marketed | May 24, 2023 | Marketed |
| APO-ELTROMBOPAG | Apotex Inc | Marketed | May 23, 2023 | Marketed |
| PRZ-METFORMIN | pharmaris canada inc | Marketed | May 23, 2023 | Marketed |
| GLN-DAPAGLIFLOZIN | glenmark pharmaceuticals canada inc. | Marketed | May 23, 2023 | Marketed |
| GLN-DAPAGLIFLOZIN | glenmark pharmaceuticals canada inc. | Marketed | May 23, 2023 | Marketed |
| APO-ELTROMBOPAG | Apotex Inc | Marketed | May 23, 2023 | Marketed |
| GABAPENTIN | Jamp Pharma Corporation | Marketed | May 19, 2023 | Marketed |
| GABAPENTIN | Jamp Pharma Corporation | Marketed | May 19, 2023 | Marketed |
| CARMUSTINE FOR INJECTION USP | Sterimax Inc | Marketed | May 18, 2023 | Marketed |
| M-DAPAGLIFLOZIN | mantra pharma inc | Marketed | May 17, 2023 | Marketed |
| SANDOZ DAPAGLIFLOZIN | Sandoz Canada, Inc. | Marketed | May 17, 2023 | Marketed |
| M-DAPAGLIFLOZIN | mantra pharma inc | Marketed | May 17, 2023 | Marketed |
| SANDOZ DAPAGLIFLOZIN | Sandoz Canada, Inc. | Marketed | May 17, 2023 | Marketed |
| AURO-DAPAGLIFLOZIN | auro pharma inc | Marketed | May 16, 2023 | Marketed |
